PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $98,000 | +55.6% | 110,000 | 0.0% | 0.00% | – |
| Q4 2016 | $63,000 | -3.1% | 110,000 | +69.2% | 0.00% | – |
| Q3 2016 | $65,000 | -54.2% | 65,000 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $142,000 | -2.1% | 65,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $145,000 | +27.2% | 65,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $114,000 | -4.2% | 65,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $119,000 | +6.2% | 65,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $112,000 | -15.2% | 65,000 | -7.1% | 0.00% | 0.0% |
| Q1 2015 | $132,000 | -23.7% | 70,000 | -17.6% | 0.00% | 0.0% |
| Q4 2014 | $173,000 | -55.8% | 85,000 | -15.0% | 0.00% | -50.0% |
| Q3 2014 | $391,000 | -54.7% | 100,000 | -33.3% | 0.00% | -60.0% |
| Q2 2014 | $863,000 | -12.8% | 150,000 | -16.7% | 0.01% | 0.0% |
| Q1 2014 | $990,000 | +7.3% | 180,000 | -5.3% | 0.01% | 0.0% |
| Q4 2013 | $923,000 | +35.7% | 190,000 | -24.0% | 0.01% | +25.0% |
| Q3 2013 | $680,000 | +4.3% | 250,000 | -15.3% | 0.00% | 0.0% |
| Q2 2013 | $652,000 | – | 295,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,797,689 | $13,597,000 | 9.60% |
| SOPHROSYNE CAPITAL LLC | 1,265,020 | $6,147,000 | 5.38% |
| Madison Street Partners, LLC | 976,653 | $4,747,000 | 4.46% |
| INTREPID CAPITAL MANAGEMENT INC /DE/ | 460,000 | $2,236,000 | 2.28% |
| Broadfin Capital, LLC | 1,230,000 | $5,978,000 | 0.79% |
| 683 Capital Management, LLC | 427,071 | $2,076,000 | 0.59% |
| AVALON CAPITAL MANAGEMENT | 138,520 | $673,000 | 0.57% |
| Cheyne Capital Management (UK) LLP | 92,700 | $451,000 | 0.49% |
| Visium Asset Management, LP | 4,350,000 | $21,141,000 | 0.42% |
| Gruss Capital Management LP | 789,811 | $3,838,000 | 0.29% |